The healthcare landscape is evolving, with a burgeoning focus on data-driven outcomes and value-based care. As the pressure to demonstrate the value of their drug to payers, payviders, and patients increases, life sciences organizations are leveraging digital companions, beyond-the-pill digital solutions that deliver personalized support and engagement programs to patients to empower sustainable behavior changes, to collect real-world evidence (RWE), drive patient outcomes, and deliver on value-based contracts (VBCs).
VBCs between payers and life sciences are becoming standard practice
Concerns stemming from patients, payers, and legislators over equitable access to medications and the long-term value generated from a drug are creating a paradigm shift in the life sciences industry. Traditional fixed-cost-per-unit models are making way for value-based contracts (VBCs), a change driven by the need for RWE of drug efficacy. While fixed-cost-per-unit models are fundamentally volume-based and not designed to reward drugs that deliver improved patient outcomes, VBCs hold life sciences accountable for their drug’s ability to achieve specific goals in a defined patient population.
Chronic disease is a significant global health challenge, with COPD being especially burdensome to patients and healthcare systems. Currently, COPD affects an estimated 480 million people worldwide1 and is the third leading cause of death.2 In the U.S., COPD accounts for 1.5 million emergency department visits annually,3 and patients with COPD incur up to $6,246 more per year in direct medical costs than other patients.4 Unfortunately, the burden of COPD is only expected to increase.
It is estimated that just 20% of health outcomes are linked to the medical care that an individual receives — the remaining 80% are estimated to stem from non-medical, societal factors like economic stability, education access and quality, healthcare access and quality, neighborhood and built environment, and social and community context.1,2
Digital platforms may play an important role in transforming respiratory care management by empowering patients to make sustainable behavior changes and enabling clinicians to deliver the right care to the right patient at the right time with medically actionable insights.
Today’s evolving healthcare landscape is placing increasing emphasis on whole-person care. The shift has led healthcare professionals (HCPs) to seek digital solutions that support them in creating personalized and engaging care journeys for their patients. Therefore, if life sciences wants to drive financial returns now and stay ahead in today’s competitive healthcare market, they must deliver what prescribers are looking for — connected medication experiences that engage patients and drive clinical outcomes.
HCPs want patient-centric medications
Prioritizing patient-centricity aligns with the healthcare industry’s broader shift toward personalized care: As many as 50% of doctors say they are more likely to prescribe medications from companies that utilize a patient-centric approach to medicine.1
The future of healthcare revolves around creating a patient-centric ecosystem. In today’s landscape, 81% of patients report being unsatisfied with their healthcare experience.1 One of the key drivers of their dissatisfaction? Lack of patient involvement: As many as 90% of patients want shared decision-making with their physician.2
Digital companions — beyond-the-pill digital solutions that deliver personalized support and engagement programs to patients to empower sustainable behavior changes — play a critical role in creating and sustaining a patient-centric healthcare ecosystem. Pairing digital health technology with medications can provide patients with personalized data and educational content that empowers them to understand and manage their condition. With real-time insights into their health, patients transition from playing a passive role in their care to becoming actively involved in their health.
That being said, life science organizations that prioritize digital health partnerships to turn traditional drug products into connected, data-driven solutions today will be the first to reap the financial returns that patient-centric medications have the power to deliver.
Digital health’s critical role in transforming healthcare and drug delivery is not a vision for a distant future — it’s the present reality. In the past three years, the top five life sciences companies have announced more than 50 investments in digital health technology companies and partnerships.1
Life sciences is transforming traditional products into data-rich, connected solutions — solutions that create a patient-centric ecosystem that benefits life sciences, clinicians, payers, and patients. With a digital companion — a beyond-the-pill digital solution that delivers personalized support and engagement programs to patients to empower sustainable behavior changes — life sciences can generate direct returns that result in financial outcomes in the form of:
Improving quality measure scores is a complex task — and it’s only getting more challenging as the list of metrics continues to grow. By prioritizing quality metric improvement, health systems, payers, and ACOs can deliver high-quality care, drive clinical outcomes across traditionally underserved patient populations, and lower costs across the board. With nine out of 10 clinicians believing digital health tools can improve patient care,1 the time is now for value-based care organizations to leverage digital health to:
Educate and motivate patients to empower sustainable behavior changes — even among traditionally underserved populations like patients covered by Medicare and Medicaid.
The use of remote monitoring devices among physicians has doubled to 30% — a 150% increase since 2016.1 While the rise of technology utilization in healthcare is promising, the industry’s digital transformation is far from over. As organizations continue to integrate digital health solutions into clinical workflows, they must also expand their understanding of everything digital health has to offer, including its ability to:
Enhance data collection and patient stratification to improve access to quality care
Viruses are one of the most frequently recorded triggers in Propeller
It’s that time of year again: fall. When pumpkin spice scents mix with hand sanitizer, costumes with masks serve a dual purpose, and germs seem to be everywhere.
For people with asthma or COPD, fall can be a tricky time to find a balance between fun, seasonal activities and the risk of getting sick. That’s because, according to the CDC, getting sick from a respiratory virus (like the flu, COVID-19, and RSV) can be more serious for people with lung conditions, and can lead to flare-ups or pneumonia.
Most people’s breathing is impacted by at least a few different things, which are called triggers. There may be times when you notice that you’re not breathing as well as you’d like to be. You may cough or feel out of breath. These reactions to triggers are called symptoms, and they aren’t random.
Here we’ll focus on triggers, why they matter and how we can help you figure out your triggers so you can better prepare for the day ahead.
A disruption to your schedule can easily throw off your adherence to your medication. You stop being able to take your dose in the morning, and suddenly you’re not taking it at all — and your symptoms are getting worse.
Here are three tips to take your dose even when your schedule changes.
1. Be intentional about changing your medication schedule.
If you have pollen allergies and asthma, the spring months can be quite a burden. Allergies can trigger asthma symptoms, causing wheezing, cough, chest tightness and shortness of breath. Here are five tips to manage your allergies during the spring months and avoid preventable asthma exacerbations.
If you have asthma or COPD, you may have noticed that cold weather affects your ability to breathe.
This may happen because cold air dries and irritates the airways, increasing inflammation and making it harder for you to breathe. You may find that you cough, wheeze or feel breathless more often when it’s cold outside.
It’s not always possible to stay inside all winter, so we’ve put together a few tips on how to manage your asthma and COPD during the colder months.